162 related articles for article (PubMed ID: 24492031)
1. [Recent issues and prospects of the treatment of aplastic anemia].
Nakao S
Rinsho Ketsueki; 2014 Jan; 55(1):5-11. PubMed ID: 24492031
[No Abstract] [Full Text] [Related]
2. [Recent progress in the management of aplastic anemia].
Nakao S
Rinsho Ketsueki; 2014 Oct; 55(10):1762-8. PubMed ID: 25297738
[No Abstract] [Full Text] [Related]
3. Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
Cheng H; Wang X; Zhou D; Cao J; Larochelle A; Xu KL
Ann Hematol; 2019 Aug; 98(8):2009-2011. PubMed ID: 30891613
[No Abstract] [Full Text] [Related]
4. Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it.
Rodgers GM; Kurtti AL; Gilreath JA
Am J Hematol; 2019 Mar; 94(3):394-395. PubMed ID: 30033660
[No Abstract] [Full Text] [Related]
5. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
[No Abstract] [Full Text] [Related]
6. Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
Quintino de Oliveira B; Catto LFB; Santana BAA; Tellechea MF; Scheucher PS; Scheinberg P; Calado RT
Br J Haematol; 2021 Apr; 193(2):410-414. PubMed ID: 33216370
[TBL] [Abstract][Full Text] [Related]
7. [Management of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia, ITP)].
Kashiwagi H; Tomiyama Y
Rinsho Ketsueki; 2014 Oct; 55(10):2087-94. PubMed ID: 25297775
[No Abstract] [Full Text] [Related]
8. Effect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteers.
Aslanis V; Zhang J; Lomeli B; Grosch K; Ouatas T
Cancer Chemother Pharmacol; 2018 Nov; 82(5):847-855. PubMed ID: 30171280
[TBL] [Abstract][Full Text] [Related]
9. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
[TBL] [Abstract][Full Text] [Related]
10. Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.
Zhao X; Feng X; Wu Z; Winkler T; Desmond R; Olnes M; Dumitriu B; Townsley DM; Dunbar CE; Young NS
Exp Hematol; 2018 Feb; 58():39-43. PubMed ID: 28941711
[TBL] [Abstract][Full Text] [Related]
11. [Thrombopoietin receptor agonist arouses new hope].
Häckel A
MMW Fortschr Med; 2016 Apr; 158(7):73. PubMed ID: 27071600
[No Abstract] [Full Text] [Related]
12. Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.
Rodgers GM; Gilreath JA
Ann Hematol; 2018 Aug; 97(8):1517-1518. PubMed ID: 29560523
[No Abstract] [Full Text] [Related]
13. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
[TBL] [Abstract][Full Text] [Related]
14. Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag.
Fattizzo B; Cavallaro F; Milesi G; Barcellini W
Am J Hematol; 2019 Sep; 94(9):E237-E239. PubMed ID: 31172568
[No Abstract] [Full Text] [Related]
15. An Eltrombopag Red (Plasma) Alert.
Al-Samkari H; Goodarzi K
Acta Haematol; 2021; 144(2):227-228. PubMed ID: 32702690
[TBL] [Abstract][Full Text] [Related]
16. Eltrombopag for the treatment of aplastic anemia: current perspectives.
Lum SH; Grainger JD
Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
[TBL] [Abstract][Full Text] [Related]
17. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
18. Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.
Fattizzo B; Kulasekararaj AG; Hill A; Benson-Quarm N; Griffin M; Munir T; Arnold L; Riley K; Ireland R; De Lavallade H; Potter V; Consonni D; Hillmen P; Mufti GJ; Barcellini W; Marsh JCW
Haematologica; 2019 Nov; 104(11):e494-e496. PubMed ID: 30890599
[No Abstract] [Full Text] [Related]
19. Aplastic Anemia.
Young NS
N Engl J Med; 2018 Oct; 379(17):1643-1656. PubMed ID: 30354958
[No Abstract] [Full Text] [Related]
20. High-dose cyclophosphamide in aplastic anaemia.
Brodsky RA; Jones RJ
Lancet; 2001 Apr; 357(9262):1128-9. PubMed ID: 11303606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
